<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="papr" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">papr</book-part-id>
      <title-group>
        <title>Renal Coloboma Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonym: Papillorenal Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Bower</surname>
            <given-names>Matthew A</given-names>
          </name>
          <xref ref-type="aff" rid="papr.AFF1"/>
          <degrees>MS</degrees>
          <email>mbower1@fairview.org</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Schimmenti</surname>
            <given-names>Lisa A</given-names>
          </name>
          <xref ref-type="aff" rid="papr.AFF2"/>
          <degrees>MD</degrees>
          <email>las@umn.edu</email>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Eccles</surname>
            <given-names>Michael R</given-names>
          </name>
          <xref ref-type="aff" rid="papr.AFF3"/>
          <degrees>PhD</degrees>
        </contrib>
      </contrib-group>
      <aff id="papr.AFF1">Division of Genetics and Metabolism, University of Minnesota Medical Center, Fairview<break/>Minneapolis, Minnesota</aff>
      <aff id="papr.AFF2">Associate Professor, Pediatrics, Ophthalmology and Genetics, Cell Biology and Development <break/>Division of Genetics and Metabolism<break/>Developmental Biology Center<break/>University of Minnesota Medical School<break/>Minneapolis, Minnesota</aff>
      <aff id="papr.AFF3">Professor and Chair in Cancer Pathology, Department of Pathology<break/>Dunedin School of Medicine<break/>University of Otago<break/>Dunedin, New Zealand </aff>
      <pub-history>
        <date iso-8601-date="2007-06-08" date-type="created">
          <day>08</day>
          <month>06</month>
          <year>2007</year>
        </date>
        <date iso-8601-date="2014-11-20" date-type="updated">
          <day>20</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="refsum" document-type="chapter">Refsum Disease</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="retinoblastoma" document-type="chapter">Retinoblastoma</related-object>
      <abstract id="papr.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Renal coloboma (papillorenal syndrome) is an autosomal dominant condition characterized by renal hypodysplasia and abnormalities of the optic nerve. Abnormal renal structure or function is noted in 92% of affected individuals; ophthalmologic abnormalities are noted in 77% of affected individuals who have pathogenic variants in <italic toggle="yes">PAX2</italic>. Renal abnormalities can be clinically silent in rare individuals. In most individuals, clinically significant renal insufficiency/renal failure is reported. End-stage renal disease requiring renal transplant is not uncommon. Ophthalmologic abnormalities are typically described as optic nerve coloboma or dysplasia. Iris colobomas have not been reported in any individual with a <italic toggle="yes">PAX2</italic> pathogenic variant. Ophthalmologic abnormalities may significantly impair vision in some individuals, while others have subtle changes only noted after detailed ophthalmologic examination. Additional clinical findings include hearing loss, which is noted in 7% of individuals with identified pathogenic variants in <italic toggle="yes">PAX2</italic>. </p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of renal coloboma syndrome is based on renal ultrasound examination and/or histologic examination, ophthalmologic findings, family history, and molecular genetic testing. <italic toggle="yes">PAX2</italic> is the only gene in which pathogenic variants are known to cause renal coloboma syndrome. Among individuals with renal hypodysplasia and characteristic abnormalities of the optic nerve, pathogenic variants in <italic toggle="yes">PAX2</italic> have been identified in approximately 50%. Among individuals with apparently nonsyndromic renal hypodysplasia, pathogenic variants in <italic toggle="yes">PAX2</italic> have been identified in approximately 7%.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Routine treatment of hypertension and/or vesicoureteral reflux; renal replacement therapy (dialysis and/or renal transplantation) for Stage 5 chronic kidney disease (CKD); low vision aids for significant visual impairment. </p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> Use of protective lenses to prevent retinal detachment. </p>
          <p><italic toggle="yes">Surveillance:</italic> Follow up by a nephrologist to monitor renal function and blood pressure and an ophthalmologist to monitor vision. </p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Offer molecular genetic testing if a <italic toggle="yes">PAX2</italic> pathogenic variant has been identified in an affected family member. If no <italic toggle="yes">PAX2</italic> pathogenic variant has been found, perform dilated ophthalmologic examination, renal ultrasound examination, tests of renal function, and urinalysis; measure blood pressure.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Renal coloboma syndrome is inherited in an autosomal dominant manner. Approximately 65% of probands with a documented <italic toggle="yes">PAX2</italic> pathogenic variant have a negative family history. In such cases, the negative family history may be explained by <italic toggle="yes">de novo</italic> mutation, unrecognized symptoms in the parents, or parental germline mosaicism for a <italic toggle="yes">PAX2</italic> pathogenic variant. Both maternal and paternal germline mosaicism, with unaffected parents having more than one affected child with a pathogenic variant, have been reported. Prenatal diagnosis and preimplantation genetic diagnosis are possible if a pathogenic <italic toggle="yes">PAX2</italic> pathogenic variant has been identified in the family. </p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="papr.Diagnosis">
        <title>Diagnosis</title>
        <sec id="papr.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of renal coloboma syndrome (papillorenal syndrome) should be suspected in individuals with the following clinical findings in the kidneys and eyes:</p>
          <sec id="papr.Renal">
            <title>Renal</title>
            <list list-type="bullet">
              <list-item>
                <p><bold>Hypoplastic kidneys</bold> characterized on ultrasound examination by hypoplasia (small size for age) and hyperechogenicity [<xref ref-type="bibr" rid="papr.REF.schimmenti.1995.204">Schimmenti et al 1995</xref>]. Renal hypoplasia is usually bilateral, although marked variability between kidneys can be observed, e.g., one small or absent kidney and one of normal size. </p>
              </list-item>
              <list-item>
                <p><bold>Renal hypodysplasia (RHD),</bold> characterized histologically by reduced number of nephrons, small kidney size, and disorganized renal tissue [<xref ref-type="bibr" rid="papr.REF.weber.2006.2864">Weber et al 2006</xref>]. Renal hypodysplasia was the most common renal finding in 114 (65%) of 173 individuals with pathogenic variants [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Multicystic dysplastic kidney,</bold> characterized histologically by cystic or dysplastic kidneys, exhibiting some degree of disorganization of the kidney architecture. Multicystic dysplastic kidneys are observed in about 6%-10% of individuals with renal coloboma syndrome [<xref ref-type="bibr" rid="papr.REF.fletcher.2005.2754">Fletcher et al 2005</xref>, <xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>]. </p>
              </list-item>
              <list-item>
                <p><bold>Oligomeganephronia,</bold> a pathologic finding characterized by fewer than normal glomeruli that are enlarged in size [<xref ref-type="bibr" rid="papr.REF.salomon.2001.457">Salomon et al 2001</xref>]. Note: Oligomeganephronia is not pathognomonic for renal coloboma syndrome. </p>
              </list-item>
              <list-item>
                <p><bold>Renal insufficiency and end-stage renal disease (ESRD).</bold> Because most data are aggregated from individual case reports and small case series, the exact incidence of Stage 5 chronic kidney disease (CKD) requiring kidney transplantation is not precisely known. Of 53 individuals with pathogenic variants in whom the age at diagnosis for Stage 5 CKD was reported, the mean age at diagnosis was 19.5 years (range: birth to 79 years) [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Vesicoureteral reflux</bold> was reported in 25 (14%) of 173 individuals with <italic toggle="yes">PAX2</italic> pathogenic variants in a large literature review and case series [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Other renal anomalies in the congenital anomalies of the kidney and urinary tract (CAKUT).</bold> Each of the following findings in the CAKUT spectrum has been reported in fewer than five individuals with <italic toggle="yes">PAX2</italic> pathogenic variants: ureteropelvic junction obstruction; medullary sponge kidney; horseshoe kidney; pyeloureteral duplication; and renal malrotation.</p>
              </list-item>
              <list-item>
                <p><bold>Uncommon non-CAKUT renal findings.</bold> Nephrolithiasis (kidney stones) has been reported in several individuals; an intrarenal teratoma was reported in a single individual [<xref ref-type="bibr" rid="papr.REF.choi.2005.481">Choi et al 2005</xref>, <xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>]. </p>
              </list-item>
            </list>
          </sec>
          <sec id="papr.Eye">
            <title>Eye</title>
            <p>The primary eye finding is <bold>dysplasia of the optic nerve,</bold> a phenotypic spectrum of optic nerve dysplasia that ranges from severe to mild. Abnormalities of the optic nerve have been identified in 125 (72%) of 173 individuals with pathogenic variants [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>].</p>
            <list list-type="bullet">
              <list-item>
                <p>The most severe form is characterized by an apparently enlarged disc in which the vessels that normally exit from the center of the disc exit instead from the periphery [<xref ref-type="bibr" rid="papr.REF.schimmenti.2003.191">Schimmenti et al 2003</xref>]. Associated abnormalities may include deep excavation of the optic nerve head with redundant fibroglial tissue. </p>
              </list-item>
              <list-item>
                <p>A milder form is an optic nerve pit characterized by a relatively localized (or sub-total) excavation of the optic disc. </p>
              </list-item>
              <list-item>
                <p>The mildest form is the exiting of the retinal vessels from the periphery of the disc without malformation of the disc itself. </p>
              </list-item>
            </list>
            <p>Note: (1) Differences exist in the terminology used to designate dysplasia of the optic nerve with abnormal passage of retinal vessels from the periphery of the optic nerve head. Some ophthalmologists refer to this finding as congenital excavation of the optic nerve and others as "optic nerve coloboma." However, the use of the term coloboma can be confusing in this setting because coloboma usually refers to non-closure of the optic fissure during the seventh week of gestation, resulting in typical uveal colobomas (iris and retinal colobomas). The developmental mechanism underlying the optic nerve abnormalities observed in renal coloboma syndrome is under investigation in animal models. (2) Some have described one of the optic nerve findings in this syndrome as "morning glory anomaly," defined as a wide and deeply excavated optic nerve with a central glial tuft and all vessels exiting abnormally at the periphery of the nerve, giving the appearance of a morning glory flower. However, it is debated whether use of the term morning glory anomaly is appropriate to describe the optic nerve malformation in renal coloboma syndrome because it may be a misnomer for the dysplasia of the optic nerve typically seen in this syndrome. </p>
            <p><bold>Retinal findings</bold> have been described in 23 (13%) of 173 individuals with pathogenic variants. Retinal coloboma (defined as absence of retinal tissue in the nasal ventral portion of the retina resulting from failure of closure of the uveal tract) has been reported in six individuals with pathogenic variants. Other retinal findings reported include: abnormal retinal pigment epithelium, abnormal retinal vessels, macular anomalies, and chorioretinal degeneration.</p>
            <p><bold>Less common associated eye malformations</bold> in individuals with documented pathogenic variants in <italic toggle="yes">PAX2</italic> [<xref ref-type="bibr" rid="papr.REF.sanyanusin.1995.2183">Sanyanusin et al 1995</xref>, <xref ref-type="bibr" rid="papr.REF.schimmenti.1995.204">Schimmenti et al 1995</xref>, <xref ref-type="bibr" rid="papr.REF.schimmenti.1999.369">Schimmenti et al 1999</xref>, <xref ref-type="bibr" rid="papr.REF.amiel.2000.820">Amiel et al 2000</xref>, <xref ref-type="bibr" rid="papr.REF.dureau.2001.1912">Dureau et al 2001</xref>, <xref ref-type="bibr" rid="papr.REF.schimmenti.2003.191">Schimmenti et al 2003</xref>, <xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>] include the following: </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Scleral staphyloma,</bold> defined as posterior bulging of the eye wall (sclera) is likely a secondary thinning of neural-crest-derived tissue in the area of the anatomically abnormal optic nerve head. Retinal thinning and myopia may be secondary to enlargement of the globe. </p>
              </list-item>
              <list-item>
                <p><bold>Optic nerve cyst,</bold> a cystic dilatation of the optic nerve posterior to the globe, is observed by cranial imaging (e.g., MRI). The cyst likely results from incomplete regression of the primordial optic stalk, followed by accumulation of fluid in its potential space. </p>
              </list-item>
              <list-item>
                <p><bold>Macular abnormalities</bold> including macular degeneration, hyperpigmentation of the macula, cystic degeneration of the macula, and papillomacular detachment have been reported in a limited number of affected individuals.</p>
              </list-item>
              <list-item>
                <p><bold>Lens abnormalities</bold> including lens opacity and posterior lens luxation have been reported in one affected individual each. It is not clear whether these findings are coincidental or related to the <italic toggle="yes">PAX2</italic> pathogenic variant.</p>
              </list-item>
            </list>
            <p>Note: (1) Some individuals with renal coloboma syndrome may not have vision loss and hence, examination of the fundus through a dilated pupil may be necessary to observe optic nerve abnormalities [<xref ref-type="bibr" rid="papr.REF.chung.2001.910">Chung et al 2001</xref>]. (2) Iris coloboma has not been observed in persons with <italic toggle="yes">PAX2</italic> pathogenic variants. </p>
          </sec>
          <sec id="papr.Other">
            <title>Other</title>
            <p>A wide range of non-renal and non-ophthalmologic findings have been reported in individuals with renal coloboma syndrome. Some of these findings, such as sensorineural hearing loss, fit with known patterns of <italic toggle="yes">PAX2</italic> expression. Hearing loss is noted in approximately 7% of individuals with pathogenic variants. Other rarely reported findings include CNS malformations, developmental delay, hyperuricemia (gout), soft skin, joint laxity, and elevated pancreatic amylase.</p>
          </sec>
        </sec>
        <sec id="papr.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of renal coloboma syndrome is established in a proband with the identification of a pathogenic variant in <italic toggle="yes">PAX2</italic> (see <xref ref-type="table" rid="papr.T.summary_of_molecular_genetic_test">Table 1</xref>).</p>
          <p><bold>One genetic testing strategy</bold> is molecular genetic testing of <italic toggle="yes">PAX2.</italic> Sequence analysis should be performed first, followed by deletion/duplication analysis if no pathogenic variant is found. </p>
          <p>A single case of renal coloboma syndrome with a <italic toggle="yes">de novo</italic> t(10;13) translocation with a breakpoint at the <italic toggle="yes">PAX2</italic> locus has been reported [<xref ref-type="bibr" rid="papr.REF.narahara.1997.213">Narahara et al 1997</xref>]. Karyotype analysis could be considered if <italic toggle="yes">PAX2</italic> sequencing and deletion/duplication analysis are non-diagnostic.</p>
          <table-wrap id="papr.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
            <label>Table 1.</label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Renal Coloboma Syndrome</p>
            </caption>
            <table>
              <tbody>
                <tr>
                  <th id="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
                <tr>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="3" colspan="1">
                    <italic toggle="yes">PAX2</italic>
                  </td>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">
                    <list list-type="bullet">
                      <list-item>
                        <p>~9/17 of patients with strictly defined renal hypodysplasia and abnormalities of the optic nerve&#x000a0;<sup>3</sup></p>
                      </list-item>
                      <list-item>
                        <p>~7% of patients presenting with apparently nonsyndromic renal hypodysplasia&#x000a0;<sup>4</sup></p>
                      </list-item>
                      <list-item>
                        <p>~50% of probands with renal and ophthalmologic findings consistent with renal coloboma syndrome&#x000a0;<sup>5</sup></p>
                      </list-item>
                      <list-item>
                        <p>~23% of patients referred for PAX2 testing in clinical diagnostic laboratories&#x000a0;<sup>6</sup></p>
                      </list-item>
                    </list>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Deletion/duplication analysis&#x000a0;<sup>7</sup></td>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">Unknown&#x000a0;<sup>8</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">Karyotyping&#x000a0;<sup>9</sup></td>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1">One case&#x000a0;<sup>10</sup></td>
                </tr>
                <tr>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_1" align="left" valign="middle" rowspan="1" colspan="1">Unknown&#x000a0;<sup>11</sup></td>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_2" align="left" valign="middle" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_b_papr.T.summary_of_molecular_genetic_test_1_1_1_3" align="left" valign="middle" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="papr.TF.1">
                <label>1.</label>
                <p>See <related-object source-id="gene" document-id="papr" object-id="papr.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="papr.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants. </p>
              </fn>
              <fn id="papr.TF.1.1">
                <label>2.</label>
                <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="papr.TF.1.2">
                <label>3.</label>
                <p><xref ref-type="bibr" rid="papr.REF.dureau.2001.1912">Dureau et al [2001]</xref>. <italic toggle="yes">PAX2</italic> pathogenic variants were identified in 9/17 patients with renal hypodysplasia and optic nerve malformations.</p>
              </fn>
              <fn id="papr.TF.1.3">
                <label>4.</label>
                <p><xref ref-type="bibr" rid="papr.REF.nishimoto.2001.1769">Nishimoto et al [2001]</xref>, <xref ref-type="bibr" rid="papr.REF.salomon.2001.457">Salomon et al [2001]</xref>, <xref ref-type="bibr" rid="papr.REF.weber.2006.2864">Weber et al [2006]</xref>, <xref ref-type="bibr" rid="papr.REF.martinovicbouriel.2010.830">Martinovic-Bouriel et al [2010]</xref>, <xref ref-type="bibr" rid="papr.REF.thomas.2011.897">Thomas et al [2011]</xref>. <italic toggle="yes">PAX2</italic> pathogenic variants were identified in 16 (7.3%) of 219 probands in these five series of individuals presenting with renal hypoplasia. Ophthalmologic examination revealed abnormalities of the optic nerve in 10/16 of these individuals.</p>
              </fn>
              <fn id="papr.TF.1.4">
                <label>5.</label>
                <p><xref ref-type="bibr" rid="papr.REF.dureau.2001.1912">Dureau et al [2001]</xref> evaluated 17 patients from 11 families with phenotypes consistent with renal coloboma syndrome. Five of the 11 families harbored a pathogenic variant in <italic toggle="yes">PAX2.</italic></p>
              </fn>
              <fn id="papr.TF.1.5">
                <label>6.</label>
                <p><xref ref-type="bibr" rid="papr.REF.bower.2011.1">Bower et al [2011]</xref>. Based on the reported experiences of laboratories in the United States, France, and New Zealand. Of 208 probands referred for analysis, 48 had pathogenic variants in <italic toggle="yes">PAX2</italic>. Individuals without a pathogenic variant referred for testing often had atypical findings such as iris coloboma.</p>
              </fn>
              <fn id="papr.TF.1.6">
                <label>7.</label>
                <p>Testing that identifies exonic or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="papr.TF.1.7">
                <label>8.</label>
                <p>Three whole-gene deletions have been reported [<xref ref-type="bibr" rid="papr.REF.benetti.2007.2076">Benetti et al 2007</xref>, <xref ref-type="bibr" rid="papr.REF.raca.2011.437">Raca et al 2011</xref>, <xref ref-type="bibr" rid="papr.REF.hoefele.2012.211">Hoefele et al 2012</xref>, <xref ref-type="bibr" rid="papr.REF.laimutis.2012.1437">Laimutis et al 2012</xref>]. These deletions involved between one and 90 additional genes beyond <italic toggle="yes">PAX2</italic>. MLPA analysis in two laboratories has not identified any instances in which whole-exon deletions within <italic toggle="yes">PAX2</italic> were identified in individuals with RCS [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>, <xref ref-type="bibr" rid="papr.REF.karger.2013.786">Karger et al 2013</xref>].</p>
              </fn>
              <fn id="papr.TF.1.8">
                <label>9.</label>
                <p>Detects a balanced translocation</p>
              </fn>
              <fn id="papr.TF.1.9">
                <label>10.</label>
                <p>A single individual with a <italic toggle="yes">de novo</italic> apparently balanced translocation with breakpoints within <italic toggle="yes">PAX2</italic> has been reported [<xref ref-type="bibr" rid="papr.REF.narahara.1997.213">Narahara et al 1997</xref>]. Because the translocation was apparently balanced, it is not clear if it would have been detected by quantitative methods such as array comparative genomic hybridization (aCGH) or MLPA.</p>
              </fn>
              <fn id="papr.TF.1.10">
                <label>11.</label>
                <p>It is estimated that about half of individuals with classic findings of renal coloboma syndrome do not have a pathogenic variant identified by sequencing of <italic toggle="yes">PAX2</italic> [<xref ref-type="bibr" rid="papr.REF.dureau.2001.1912">Dureau et al 2001</xref>]. Thus, genetic heterogeneity is a possibility. </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Test characteristics.</bold> Information on test sensitivity and specificity as well as other test characteristics can be found at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.eurogentest.org/">EuroGentest</ext-link> [<xref ref-type="bibr" rid="papr.REF.bower.2011.1">Bower et al 2011</xref>] (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.nature.com/ejhg/journal/v19/n9/full/ejhg201116a.html">full text</ext-link>).</p>
        </sec>
      </sec>
      <sec id="papr.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="papr.Natural_History">
          <title>Clinical Description</title>
          <p>Renal coloboma syndrome is characterized by hypodysplastic kidneys and optic nerve abnormalities (most commonly optic nerve dysplasia) with or without optic nerve or retinal coloboma [<xref ref-type="bibr" rid="papr.REF.schimmenti.2003.191">Schimmenti et al 2003</xref>].</p>
          <p>The clinical findings vary even within families, with some family members having either renal manifestations or optic nerve abnormalities and others having both. The severity of renal malformations can range within a family from absence of clinical symptoms to severe fetal renal failure.</p>
          <p>In some instances a detailed eye examination is necessary to reveal the ocular findings of renal coloboma syndrome in individuals presenting with characteristic renal findings. For example:</p>
          <list list-type="bullet">
            <list-item>
              <p>In 20 probands ascertained for apparently isolated renal hypoplasia/dysplasia without known eye malformations, <xref ref-type="bibr" rid="papr.REF.nishimoto.2001.1769">Nishimoto et al [2001]</xref> found <italic toggle="yes">PAX2</italic> pathogenic variants in two &#x02014; one of whom had eye findings consistent with renal coloboma syndrome on ophthalmologic examination. </p>
            </list-item>
            <list-item>
              <p>Of nine probands ascertained for oligomeganephronia by <xref ref-type="bibr" rid="papr.REF.salomon.2001.457">Salomon et al [2001]</xref>, three were found to have a <italic toggle="yes">PAX2</italic> pathogenic variant. On further evaluation all three with a <italic toggle="yes">PAX2</italic> pathogenic variant were found to have minor eye findings consistent with renal coloboma syndrome; none had visual impairment. </p>
            </list-item>
            <list-item>
              <p>In an individual who had undergone renal transplantation for end-stage renal disease (ESRD), an optic nerve coloboma was found incidentally. Subsequently a pathogenic variant in <italic toggle="yes">PAX2</italic> was identified [<xref ref-type="bibr" rid="papr.REF.chung.2001.910">Chung et al 2001</xref>]. </p>
            </list-item>
          </list>
          <p>Conversely, in a family ascertained because of poor vision with optic disc abnormalities and abnormal optic disc vasculature, <xref ref-type="bibr" rid="papr.REF.parsa.2001.738">Parsa et al [2001]</xref> found renal hypoplasia in several members and previously unsuspected ESRD in one family member. Molecular genetic testing for <italic toggle="yes">PAX2</italic> was carried out; no pathogenic variants were identified.</p>
          <p><bold>Renal disease.</bold> Renal insufficiency/failure can occur at any age. The age at diagnosis of Stage 5 chronic kidney disease ranges from birth to 79 years.</p>
          <p>The natural history of vesicoureteral reflux varies: in some individuals ureteral reimplantation has been required [<xref ref-type="bibr" rid="papr.REF.schimmenti.1995.204">Schimmenti et al 1995</xref>]; in others the reflux has spontaneously resolved [<xref ref-type="bibr" rid="papr.REF.ford.2001.137">Ford et al 2001</xref>].</p>
          <p><bold>Eye abnormalities.</bold> Impaired visual acuity of one or both eyes is present in 75% of affected individuals; acuity ranges from light perception only to normal. Other findings can include nystagmus, myopia, and strabismus. </p>
          <p>The natural history of visual acuity in individuals with renal coloboma syndrome has not been prospectively studied. In some instances, significant changes in visual acuity have been reported. Visual acuity deteriorated in one person as a result of retinal detachment [<xref ref-type="bibr" rid="papr.REF.ford.2001.137">Ford et al 2001</xref>]. One person previously reported acute vision loss resulting in a change of visual acuity from 20/80 to light perception only [<xref ref-type="bibr" rid="papr.REF.schimmenti.1995.204">Schimmenti et al 1995</xref>]; however, the cause of vision loss was unexplained as there was no evidence of detachment or macular changes [Schimmenti, unpublished observation].</p>
          <p><bold>Other.</bold> Less commonly reported findings in affected individuals include high-frequency hearing loss, soft skin, and ligamentous laxity. The age of onset of hearing loss and progression of hearing loss remain unknown and have not been evaluated prospectively. The hearing loss, when present, has been discovered in childhood and is bilateral high-frequency sensorineural hearing loss</p>
        </sec>
        <sec id="papr.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Some authors have observed that pathogenic variants in exons 7-9 result in renal hypoplasia/dysplasia and milder ocular findings [<xref ref-type="bibr" rid="papr.REF.porteous.2000.1">Porteous et al 2000</xref>, <xref ref-type="bibr" rid="papr.REF.nishimoto.2001.1769">Nishimoto et al 2001</xref>]. Others have argued that renal disease results from a haploinsufficiency mechanism, while ocular findings are the result of dominant-negative effects [<xref ref-type="bibr" rid="papr.REF.benetti.2007.2076">Benetti et al 2007</xref>]. </p>
          <p>Review of all reported cases to date does not reveal a consistent genotype/phenotype correlation. This is most dramatically illustrated by the tremendous variability in the severity of ocular and renal findings <italic toggle="yes">within</italic> families. To date, no clear evidence suggests that the location of a pathogenic variant (paired domain, octapeptide domain, partial homeodomain, or trans-activation domain) or the type of mutation (missense mutation, nonsense mutation, or gene deletion) consistently predicts the clinical phenotype. </p>
        </sec>
        <sec id="papr.Penetrance">
          <title>Penetrance</title>
          <p>One individual with a pathogenic variant in whom renal and ophthalmologic examinations are normal has been reported [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>]. Thus, penetrance appears to be greater than 99%. In individuals with pathogenic variants in <italic toggle="yes">PAX2</italic>, the penetrance of eye malformations is at least 77% [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>]. This should be viewed as a minimum figure, as fully 21% of individuals with <italic toggle="yes">PAX2</italic> pathogenic variants have not had a dilated eye examination to evaluate for subclinical abnormalities of the optic nerve. The penetrance for renal malformations or renal disease is at least 92%. Again, this figure should be viewed as a minimum, as some individuals with pathogenic variants have not had full renal evaluations.</p>
        </sec>
        <sec id="papr.Nomenclature">
          <title>Nomenclature</title>
          <p>Terms previously used for renal coloboma syndrome:</p>
          <list list-type="bullet">
            <list-item>
              <p>Coloboma-ureteral-renal syndrome </p>
            </list-item>
            <list-item>
              <p>Optic nerve coloboma with renal disease </p>
            </list-item>
            <list-item>
              <p>Coloboma of the optic nerve with renal disease </p>
            </list-item>
            <list-item>
              <p>Optic coloboma-vesicoureteral reflux-renal anomalies </p>
            </list-item>
          </list>
        </sec>
        <sec id="papr.Prevalence">
          <title>Prevalence</title>
          <p>The prevalence of renal coloboma syndrome is unknown. More than 180 affected individuals with pathogenic variants have been reported worldwide. The number of individuals without pathogenic variants who have classic findings of renal coloboma syndrome is not known. There is no evidence for a significant founder effect in any population.</p>
        </sec>
      </sec>
      <sec id="papr.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><xref ref-type="bibr" rid="papr.REF.nishimoto.2001.1769">Nishimoto et al [2001]</xref> suggested that the finding of apparently isolated renal hypoplasia in two (10%) of 20 probands with a <italic toggle="yes">PAX2</italic> pathogenic variant represent allelic heterogeneity in <italic toggle="yes">PAX2</italic> pathogenic variants (see <xref ref-type="sec" rid="papr.Clinical_Description">Clinical Characteristics</xref>). One of the affected individuals in the group was subsequently found to have eye malformations. Further studies have demonstrated that <italic toggle="yes">PAX2</italic> pathogenic variants can be identified in cohorts of individuals with renal hypodysplasia. <xref ref-type="bibr" rid="papr.REF.weber.2006.2864">Weber et al [2006]</xref> identified seven individuals with pathogenic variants in six of 99 European families with congenital anomalies of the kidney and urinary tract (CAKUT), for a prevalence of 7%. In this group, five affected individuals had previously undiagnosed eye abnormalities. In a North American cohort of 73 probands with CAKUT, three with apparently nonsyndromic renal hypodysplasia were identified to have pathogenic variants in <italic toggle="yes">PAX2</italic>, for a prevalence of 4% [<xref ref-type="bibr" rid="papr.REF.thomas.2011.897">Thomas et al 2011</xref>]. In a cohort of patients with focal segmental glomerular sclerosis (FSGS), 7% were found to have rare amino acid substitutions predicted to perturb PAX2 function [<xref ref-type="bibr" rid="papr.REF.barua.2014.1942">Barua et al 2014</xref>]. </p>
      </sec>
      <sec id="papr.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><related-object link-type="booklink" source-id="gene" document-id="charge" document-type="chapter"><bold>CHARGE syndrome</bold></related-object>. Renal dysplasia and retinal/optic nerve colobomas are major findings in CHARGE syndrome (<italic toggle="yes">c</italic>oloboma, <italic toggle="yes">h</italic>eart malformations, <italic toggle="yes">a</italic>tresia choanae, <italic toggle="yes">r</italic>etardation of <italic toggle="yes">g</italic>rowth and development, <italic toggle="yes">g</italic>enital abnormalities, <italic toggle="yes">e</italic>ar and hearing defects). Pathogenic variants in <italic toggle="yes">PAX2</italic> were not identified in a small series of persons with CHARGE syndrome [<xref ref-type="bibr" rid="papr.REF.tellier.2000.85">Tellier et al 2000</xref>; Schimmenti, unpublished]. An estimated 65%-70% of individuals with CHARGE syndrome have pathogenic variants in or deletions of <italic toggle="yes">CHD7</italic>. </p>
        <p><bold>Oligomeganephronia.</bold> Kidney phenotypes overlapping oligomeganephronia in renal coloboma syndrome have also been associated with <related-object link-type="booklink" source-id="gene" document-id="bor" document-type="chapter">branchiootorenal syndrome</related-object> (<italic toggle="yes">EYA1</italic> pathogenic variants) [<xref ref-type="bibr" rid="papr.REF.sikora.2001.291">Sikora et al 2001</xref>], chromosome 4p deletions (see <related-object link-type="booklink" source-id="gene" document-id="whs" document-type="chapter">Wolf-Hirschhorn syndrome</related-object>), or ring chromosome 4 mosaicism; or found in association with diabetes mellitus in persons with <italic toggle="yes">HNF1B</italic> (<italic toggle="yes">TCF2</italic>) pathogenic variants [<xref ref-type="bibr" rid="papr.REF.bohn.2003.2033">Bohn et al 2003</xref>].</p>
        <p><bold>Cat-eye syndrome</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/115470">115470</ext-link>). Colobomatous eye defects and kidney abnormalities are manifestations of cat-eye syndrome caused by tetraploid dosage of proximal 22q. However, individuals with PAX2 mutations do not have iris colobomas. </p>
        <p><bold><italic toggle="yes">PAX6</italic> pathogenic variants.</bold> Eye phenotypes overlapping with renal coloboma syndrome have been reported in individuals with pathogenic variants in <italic toggle="yes">PAX6</italic> (see <related-object link-type="booklink" source-id="gene" document-id="aniridia" document-type="chapter">Aniridia</related-object>) [<xref ref-type="bibr" rid="papr.REF.azuma.2003.1565">Azuma et al 2003</xref>]. </p>
        <p><bold>COACH syndrome</bold> (<italic toggle="yes">c</italic>erebral vermis hypoplasia, <italic toggle="yes">o</italic>ligophrenia, <italic toggle="yes">a</italic>taxia, optic nerve <italic toggle="yes">c</italic>oloboma, <italic toggle="yes">h</italic>epatic fibrosis) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/216360">216360</ext-link>) [<xref ref-type="bibr" rid="papr.REF.verloes.1989.227">Verloes &#x00026; Lambotte 1989</xref>, <xref ref-type="bibr" rid="papr.REF.gentile.1996.514">Gentile et al 1996</xref>] has overlapping findings. Persons with renal coloboma syndrome typically do not have developmental disability or hepatic findings. </p>
        <p><related-object link-type="booklink" source-id="gene" document-id="joubert" document-type="chapter"><bold>Joubert syndrome and related disorders</bold></related-object>
<bold>(JSRD).</bold> Joubert syndrome is characterized by a distinctive cerebellar and brain stem malformation (the "molar tooth sign" seen on cranial MRI), hypotonia, developmental delays, and either episodic hyperpnea (or apnea) or atypical eye movements, or both. Most children with Joubert syndrome develop truncal ataxia. Other features sometimes observed include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. To date pathogenic variants in one of more than twenty genes have been identified in about 50% of individuals with a JSRD. Inheritance is most commonly autosomal recessive. </p>
        <p>In contrast to Joubert syndrome, renal coloboma syndrome does not typically include developmental disability. </p>
      </sec>
      <sec id="papr.Management">
        <title>Management</title>
        <sec id="papr.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with renal coloboma syndrome, the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Evaluation of renal structure by renal ultrasound examination </p>
            </list-item>
            <list-item>
              <p>Measurement of renal function by serum electrolyte concentrations, BUN, and creatinine </p>
            </list-item>
            <list-item>
              <p>Urinalysis to evaluate for the presence of blood and protein </p>
            </list-item>
            <list-item>
              <p>Evaluation for vesicoureteral reflux, by voiding cytourethrogram (VCUG) if clinically indicated </p>
            </list-item>
            <list-item>
              <p>Dilated eye examination </p>
            </list-item>
            <list-item>
              <p>Audiologic assessment (See <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object> for details of audiologic assessment.) </p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="papr.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>A team approach that includes specialists in ophthalmology, nephrology, medical genetics, and audiology is recommended. </p>
          <p>Management is focused on preventing complications of end-stage renal disease (ESRD) and/or vision loss resulting from retinal detachment. </p>
          <list list-type="bullet">
            <list-item>
              <p>Treatment of hypertension and/or vesicoureteral reflux (if present) may preserve renal function. </p>
            </list-item>
            <list-item>
              <p>ESRD is treated with renal replacement therapy (i.e., dialysis and/or renal transplantation).</p>
            </list-item>
            <list-item>
              <p>Low vision experts can assist with adaptive functioning of those with significant vision loss. </p>
            </list-item>
          </list>
        </sec>
        <sec id="papr.Prevention_of_Primary_Manifestation">
          <title>Prevention of Primary Manifestations</title>
          <p>For patients with known mutation of <italic toggle="yes">PAX2</italic>, regular monitoring of blood pressure, BUN/creatinine, electrolytes, and urine analysis and serum studies of renal function are indicated to allow for early diagnosis, as more than 90% of affected patients will develop ESRD. </p>
        </sec>
        <sec id="papr.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Prevention of retinal detachment in those with congenital optic nerve abnormalities includes close follow up with an ophthalmologist and use of protective lenses. </p>
        </sec>
        <sec id="papr.Surveillance">
          <title>Surveillance</title>
          <p>No disease-specific guidelines have been developed. The following ongoing evaluations are recommended in all individuals in whom pathogenic variants have been confirmed.</p>
          <list list-type="bullet">
            <list-item>
              <p>Follow up by a nephrologist to monitor renal function and blood pressure </p>
            </list-item>
            <list-item>
              <p>Follow up by an ophthalmologist to monitor vision. Any change in vision could indicate a retinal detachment and should be treated as a medical emergency. </p>
            </list-item>
            <list-item>
              <p>Audiometric evaluation with periodic follow up</p>
            </list-item>
          </list>
        </sec>
        <sec id="papr.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Consultation with a specialist in nephrology before using medications known to impact renal function is appropriate.</p>
        </sec>
        <sec id="papr.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures. </p>
          <list list-type="bullet">
            <list-item>
              <p>If the <italic toggle="yes">PAX2</italic> pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant in the family is not known, dilated ophthalmologic examination and renal ultrasound examination, tests of renal function, urinalysis, and blood pressure evaluation should be performed.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="papr.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="papr.Pregnancy_Management">
          <title>Pregnancy Management </title>
          <p>It is important that a female who has a pathogenic variant have a thorough renal evaluation prior to becoming pregnant. Individuals with clinical renal disease should consult with appropriate professionals including nephrologists and maternal fetal medicine specialists to establish a plan for medical management during pregnancy. </p>
          <p>Pregnancies at 50% risk for renal coloboma syndrome should be monitored for fetal renal function. Comprehensive ultrasound in the second trimester is recommended to evaluate fetal renal anatomy. Ongoing monitoring for oligohydramnios in the second and third trimesters is recommended in at-risk pregnancies.</p>
          <p>Eighteen individuals with pathogenic variants have been reported to have prenatal ultrasound abnormalities including oligohydramnios/anhydramnios, cystic renal dysplasia, multicystic dysplastic kidneys, and renal hypoplasia [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>]. Seven fetuses with a confirmed <italic toggle="yes">PAX2</italic> pathogenic variant and severe prenatal renal failure (Potter sequence) have been reported [<xref ref-type="bibr" rid="papr.REF.martinovicbouriel.2010.830">Martinovic-Bouriel et al 2010</xref>, <xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>]. In addition, four cases of severe prenatal renal failure have been reported in families with renal coloboma syndrome in which the presence of the familial pathogenic variant could not be verified in the affected fetus [<xref ref-type="bibr" rid="papr.REF.ford.2001.137">Ford et al 2001</xref>, <xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>]. In several instances, parents with mild renal disease had pregnancies where the fetus presented with severe renal disease in utero.</p>
        </sec>
        <sec id="papr.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="papr.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="papr.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Renal coloboma syndrome is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="papr.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Approximately 65% of probands with a documented <italic toggle="yes">PAX2</italic> pathogenic variant have a negative family history. In such cases, the negative family history may be explained by <italic toggle="yes">de novo</italic> mutation, unrecognized symptoms in the parents, and/or parental germline mosaicism for a <italic toggle="yes">PAX2</italic> pathogenic variant. </p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, two possible explanations are germline mosaicism in a parent or <italic toggle="yes">de novo</italic> mutation in the proband. Both maternal and paternal germline mosaicism have been reported in renal coloboma syndrome [<xref ref-type="bibr" rid="papr.REF.amiel.2000.820">Amiel et al 2000</xref>, <xref ref-type="bibr" rid="papr.REF.cheong.2007.1283">Cheong et al 2007</xref>]. </p>
              <list list-type="bullet">
                <list-item>
                  <p>Ophthalmologic abnormalities consistent with renal coloboma syndrome have been reported in a parent without a <italic toggle="yes">PAX2</italic> pathogenic variant who has two children with pathogenic variants. It was hypothesized that this parent had somatic (and germline) mosaicism, but the pathogenic variant was absent in the tissues analyzed (leukocytes, fibroblasts, oral mucosa) [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> mutation include molecular genetic testing if the <italic toggle="yes">PAX2</italic> pathogenic variant has been identified in the proband. If the <italic toggle="yes">PAX2</italic> pathogenic variant has not been identified, dilated ophthalmologic evaluation and renal evaluation are recommended. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed. </p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents. </p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is clinically affected or is known to harbor the familial pathogenic variant, the risk to the sibs of inheriting the <italic toggle="yes">PAX2</italic> pathogenic variant is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low, but greater than that of the general population because of the risk for germline mosaicism. Germline mosaicism, in which parents who do not have a pathogenic variant have more than one affected child with a pathogenic variant, has been documented in approximately 4% of families with renal coloboma syndrome [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with renal coloboma syndrome has a 50% chance of inheriting the <italic toggle="yes">PAX2</italic> pathogenic variant. </p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents. </p>
            </list-item>
            <list-item>
              <p>If a parent is affected or has a <italic toggle="yes">PAX2</italic> pathogenic variant, his or her family members are at risk. </p>
            </list-item>
          </list>
        </sec>
        <sec id="papr.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See <xref ref-type="sec" rid="papr.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Testing of at-risk asymptomatic relatives</bold> of individuals with renal coloboma syndrome is possible after molecular genetic testing has identified the specific <italic toggle="yes">PAX2</italic> pathogenic variant in the family. Testing could be used to clarify the genetic status of at-risk relatives in order to begin expectant management of renal disease and/or eye disease. Such testing should be performed in the context of formal genetic counseling. This testing is not useful in predicting age of onset, severity, type of symptoms, or rate of progression in asymptomatic individuals. Testing of asymptomatic at-risk individuals with nonspecific or equivocal symptoms is predictive testing, not diagnostic testing. Note: Testing of asymptomatic individuals younger than age 18 years is appropriate to consider in families with an established diagnosis of renal coloboma syndrome in order to guide vision and renal management. </p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with renal coloboma syndrome has the pathogenic variant or clinical evidence of the disorder, the <italic toggle="yes">PAX2</italic> mutation is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored. </p>
          <p><bold>Family planning</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="papr.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Molecular genetic testing.</bold> If the <italic toggle="yes">PAX2</italic> pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing. </p>
          <p>Requests for prenatal testing for conditions which (like renal coloboma syndrome) do not affect intellect and have some treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate. </p>
          <p><bold>Prenatal fetal ultrasound examination of an at-risk pregnancy or known affected pregnancy</bold> may be used during the later stages of pregnancy to detect renal malformations and assess amniotic fluid volume, as findings could affect the well-being of the newborn or warrant further evaluation after birth. </p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the <italic toggle="yes">PAX2</italic> pathogenic variant has been identified. </p>
        </sec>
      </sec>
      <sec id="papr.Resources">
        <title>Resources</title>
      </sec>
      <sec id="papr.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="papr.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The pattern of abnormalities in renal coloboma syndrome is consistent with the known expression pattern of <italic toggle="yes">PAX2</italic> during embryonic development. <xref ref-type="bibr" rid="papr.REF.porteous.2000.1">Porteous et al [2000]</xref> and <xref ref-type="bibr" rid="papr.REF.torban.2000.833">Torban et al [2000]</xref> have demonstrated in mouse models and tissue culture that normal biallelic <italic toggle="yes">PAX2</italic> expression is needed to prevent programmed cell death. </p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">PAX2</italic> contains 12 coding exons. Alternative splicing of this gene results in multiple transcript variants. The longest transcript variant, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003990.3">NM_003990.3</ext-link>, has 11 exons. None of the known transcripts contains all 12 coding exons. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="papr" object-id="papr.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic allelic variants.</bold> See <related-object source-id="gene" document-id="papr" object-id="papr.molgen.TA">Table A</related-object>, <bold>Locus Specific</bold>. To date, approximately 60 pathogenic variants have been reported in the <italic toggle="yes">PAX2</italic> coding exons and adjoining intronic sequences [<xref ref-type="bibr" rid="papr.REF.bower.2012.457">Bower et al 2012</xref>]. Frameshift mutations are the most common type; nonsense, splice site changes, missense, and in-frame duplications have also been reported. Mutations tend to cluster in the paired domain (exons 2-4), the homeodomain (exon 7), and the 5&#x02019; portion of the trans-activation domain (exon 8). A limited number of missense variants have been reported in exons 9-12, but the pathogenicity of these variants is not clearly established. A small number of genomic deletions and rearrangements have been reported. MLPA studies have not identified partial-gene deletion as a common mutation mechanism [<xref ref-type="bibr" rid="papr.REF.karger.2013.786">Karger et al 2013</xref>].</p>
          <p><bold>Normal gene product.</bold>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003990.3">NM_003990.3</ext-link> encodes a PAX-2 isoform of 431 amino acids (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_003981.2">NP_003981.2</ext-link>). Paired box protein PAX-2 is a DNA-binding protein characterized by an N-terminal paired domain, a bipartite helix-loop-helix domain, a small octapeptide domain, a truncated homeodomain, and a proline/serine/threonine-rich C-terminal domain. Multiple isoforms, by alternative splicing of exons 6, 10, and 12, are known to exist. </p>
          <p><bold>Abnormal gene product.</bold> The majority of <italic toggle="yes">PAX2</italic> pathogenic variants are expected to result either in the loss of expression from one allele or in expression of a significantly truncated protein. The most common recurring pathogenic variant is the c.76dup pathogenic variant (previously called c.619insG). This pathogenic variant, which results from the insertion of an extra guanine residue in a stretch of seven guanine residues, has been reported in more than 25 independent families. Nonsense, frameshift, and splice mutations have been reported in all four functional domains of <italic toggle="yes">PAX2</italic>.</p>
          <p>To date, all clearly pathogenic in-frame mutations (missense, in-frame deletions, and in-frame duplications) are located in the paired domain (exons 2-4). It is not known if these pathogenic variants exert their effect by reducing the binding to normal DNA targets or by allowing binding to abnormal DNA targets. Six missense variants have been reported outside of the paired domain. Each of these variants has been reported in a single individual and the evidence for pathogenicity is not as strong as with other <italic toggle="yes">PAX2</italic> variants.</p>
        </sec>
      </sec>
      <sec id="papr.References">
        <title>References</title>
        <sec id="papr.Published_GuidelinesConsensus_State">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="papr.Published_GuidelinesConsensus_State.reflist0">
            <ref id="papr.REF.americansocietyofhumange.1995.1">
              <mixed-citation publication-type="book">American Society of Human Genetics and American College of Medical Genetics. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1801355/pdf/ajhg00037-0249.pdf">online</ext-link>. 1995. Accessed 11-13-14.</mixed-citation>
            </ref>
            <ref id="papr.REF.nationalsocietyofgenetic.2012.1">
              <mixed-citation publication-type="book">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset disorders. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://nsgc.org/p/bl/et/blogid=47&#x00026;blogaid=28">online</ext-link>. 2012. Accessed 11-13-14.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="papr.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="papr.Literature_Cited.reflist0">
            <ref id="papr.REF.amiel.2000.820">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audollent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joly</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dureau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tellier</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouissou</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gubler</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>PAX2 mutations in renal-coloboma syndrome: mutational hotspot and germline mosaicism.</article-title>
                <source>Eur J Hum Genet</source>
                <year>2000</year>
                <volume>8</volume>
                <fpage>820</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11093271</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.azuma.2003.1565">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azuma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Handa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadokoro</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asaka</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawase</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Mutations of the PAX6 gene detected in patients with a variety of optic-nerve malformations.</article-title>
                <source>Am J Hum Genet</source>
                <year>2003</year>
                <volume>72</volume>
                <fpage>1565</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">12721955</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.barua.2014.1942">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barua</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stellacci</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stella</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weins</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Genovese</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muto</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caputo</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toka</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charoonratana</surname>
                    <given-names>VT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tartaglia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollak</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in PAX2 associate with adult-onset FSGS.</article-title>
                <source>J Am Soc Nephrol.</source>
                <year>2014</year>
                <volume>25</volume>
                <fpage>1942</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">24676634</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.benetti.2007.2076">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Benetti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artifoni</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salviati</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinello</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrotta</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuffardi</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zacchello</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murer</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Renal hypoplasia without optic coloboma associated with PAX2 gene deletion.</article-title>
                <source>Nephrol Dial Transplant</source>
                <year>2007</year>
                <volume>22</volume>
                <fpage>2076</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17403695</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.bohn.2003.2033">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bohn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bingham</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattersley</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryffel</surname>
                    <given-names>GU</given-names>
                  </name>
                </person-group>
                <article-title>Distinct molecular and morphogenetic properties of mutations in the human HNF1beta gene that lead to defective kidney development.</article-title>
                <source>J Am Soc Nephrol</source>
                <year>2003</year>
                <volume>14</volume>
                <fpage>2033</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">12874457</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.bower.2011.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bower</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heidet</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <article-title>Clinical utility gene card for: renal coloboma (Papillorenal) syndrome.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2011</year>
                <volume>19</volume>
                <issue>9</issue>
                <pub-id pub-id-type="pmid">21326282</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.bower.2012.457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bower</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allanson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benedicenti</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benetti</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Binenbaum</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jensen</surname>
                    <given-names>UB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cochat</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeCramer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dixon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falk</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feret</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gise</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lavocat</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morini&#x000e8;re</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mowat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murer</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nguyen</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peretz-Amit</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierce</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Place</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodig</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salerno</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sastry</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sayer</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaafsma</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shoemaker</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stockton</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tenconi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanhille</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vats</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weleber</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson-Brackett</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zand</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heidet</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <article-title>Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus specific database.</article-title>
                <source>Hum Mutat</source>
                <year>2012</year>
                <volume>33</volume>
                <fpage>457</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">22213154</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.cheong.2007.1283">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cheong</surname>
                    <given-names>HI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ha</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>A clinico-genetic study of renal coloboma syndrome in children.</article-title>
                <source>Pediatr Nephrol</source>
                <year>2007</year>
                <volume>22</volume>
                <fpage>1283</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17541647</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.choi.2005.481">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fraire</surname>
                    <given-names>AE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baiyee</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Best cases from the AFIP: intrarenal teratoma.</article-title>
                <source>Radiographics.</source>
                <year>2005</year>
                <volume>25</volume>
                <fpage>481</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">15798064</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.chung.2001.910">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>AO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manligas</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ritter</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Renal coloboma syndrome: report of a novel PAX2 gene mutation.</article-title>
                <source>Am J Ophthalmol</source>
                <year>2001</year>
                <volume>132</volume>
                <fpage>910</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">11730657</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.dureau.2001.1912">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Dureau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bettembourg</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uteza</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufier</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Renal coloboma syndrome.</article-title>
                <source>Ophthalmology</source>
                <year>2001</year>
                <volume>108</volume>
                <fpage>1912</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11581073</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.fletcher.2005.2754">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fletcher</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berman</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grigg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McIver</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juppner</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexander</surname>
                    <given-names>SI</given-names>
                  </name>
                </person-group>
                <article-title>Multicystic dysplastic kidney and variable phenotype in a family with a novel deletion mutation of PAX2.</article-title>
                <source>J Am Soc Nephrol</source>
                <year>2005</year>
                <volume>16</volume>
                <fpage>2754</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">16049068</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.ford.2001.137">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ford</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rupps</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lirenman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Allen</surname>
                    <given-names>MI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farquharson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyons</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <article-title>Renal-coloboma syndrome: prenatal detection and clinical spectrum in a large family.</article-title>
                <source>Am J Med Genet</source>
                <year>2001</year>
                <volume>99</volume>
                <fpage>137</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">11241473</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.gentile.1996.514">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gentile</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Di Carlo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susca</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambotto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caruso</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panella</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vajro</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guanti</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>COACH syndrome: report of two brothers with congenital hepatic fibrosis, cerebellar vermis hypoplasia, oligophrenia, ataxia, and mental retardation.</article-title>
                <source>Am J Med Genet</source>
                <year>1996</year>
                <volume>64</volume>
                <fpage>514</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">8862632</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.hoefele.2012.211">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoefele</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinrich</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benz</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rompel</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rost</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klein</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunstmann</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>A novel interstitial deletion of 10q24.2q24.32 in a patient with renal coloboma syndrome.</article-title>
                <source>Eur J Med Genet.</source>
                <year>2012</year>
                <volume>55</volume>
                <fpage>211</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">22361651</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.karger.2013.786">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karger</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bower</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thyagarajan</surname>
                    <given-names>B.</given-names>
                  </name>
                </person-group>
                <article-title>Detection of PAX2 deletions and duplications using multiplex ligation-dependent probe amplification.</article-title>
                <source>Genet Test Mol Biomarkers.</source>
                <year>2013</year>
                <volume>17</volume>
                <fpage>786</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">23756089</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.laimutis.2012.1437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Laimutis</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarunas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andriuskeviciute</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birute</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raca</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Typical renal coloboma syndrome in a patient with a submicroscopic deletion of the PAX2 gene.</article-title>
                <source>Am J Med Genet</source>
                <year>2012</year>
                <volume>158A</volume>
                <fpage>1437</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">22581475</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.martinovicbouriel.2010.830">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Martinovic-Bouriel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benachi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonni&#x000e8;re</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brahimi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esculpavit</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morichon</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Encha-Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atti&#x000e9;-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gubler</surname>
                    <given-names>MC</given-names>
                  </name>
                </person-group>
                <article-title>PAX2 mutations in fetal renal hypodysplasia.</article-title>
                <source>Am J Med Genet A</source>
                <year>2010</year>
                <volume>152A</volume>
                <fpage>830</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20358591</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.narahara.1997.213">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Narahara</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baker</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokoyama</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hewitt</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutherland</surname>
                    <given-names>GR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>RI</given-names>
                  </name>
                </person-group>
                <article-title>Localisation of a 10q breakpoint within the PAX2 gene in a patient with a de novo t(10;13) translocation and optic nerve coloboma-renal disease.</article-title>
                <source>J Med Genet</source>
                <year>1997</year>
                <volume>34</volume>
                <fpage>213</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">9132492</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.nishimoto.2001.1769">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishimoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iijima</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirakawa</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitagawa</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Satomura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshikawa</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <article-title>PAX2 gene mutation in a family with isolated renal hypoplasia.</article-title>
                <source>J Am Soc Nephrol</source>
                <year>2001</year>
                <volume>12</volume>
                <fpage>1769</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">11461952</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.parsa.2001.738">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Parsa</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sundin</surname>
                    <given-names>OH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jong</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunness</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeimer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hunter</surname>
                    <given-names>DG</given-names>
                  </name>
                </person-group>
                <article-title>Redefining papillorenal syndrome: an underdiagnosed cause of ocular and renal morbidity.</article-title>
                <source>Ophthalmology</source>
                <year>2001</year>
                <volume>108</volume>
                <fpage>738</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">11297491</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.porteous.2000.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Porteous</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Torban</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>NP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunliffe</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chua</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNoe</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ward</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Souza</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gus</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giugliani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sato</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yun</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favor</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sicotte</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodyer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +/- mutant mice.</article-title>
                <source>Hum Mol Genet</source>
                <year>2000</year>
                <volume>9</volume>
                <fpage>1</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">10587573</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.raca.2011.437">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Raca</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jackson</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kucinskas</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warman</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shieh</surname>
                    <given-names>JTC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardakjian</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <article-title>Array comparative genomic hybridization analysis in patients with anophthalmia, microphthalmia, and coloboma.</article-title>
                <source>Genet Med</source>
                <year>2011</year>
                <volume>13</volume>
                <fpage>437</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">21285886</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.salomon.2001.457">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salomon</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tellier</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dureau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niaudet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gubler</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broyer</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>PAX2 mutations in oligomeganephronia.</article-title>
                <source>Kidney Int</source>
                <year>2001</year>
                <volume>59</volume>
                <fpage>457</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">11168927</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.sanyanusin.1995.2183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sanyanusin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McNoe</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weaver</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>MR</given-names>
                  </name>
                </person-group>
                <article-title>Mutation of PAX2 in two siblings with renal-coloboma syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <year>1995</year>
                <volume>4</volume>
                <fpage>2183</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">8589702</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.schimmenti.2003.191">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manligas</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieving</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>Optic nerve dysplasia and renal insufficiency in a family with a novel PAX2 mutation, Arg115X: further ophthalmologic delineation of the renal-coloboma syndrome.</article-title>
                <source>Ophthalmic Genet</source>
                <year>2003</year>
                <volume>24</volume>
                <fpage>191</fpage>
                <lpage>202</lpage>
                <pub-id pub-id-type="pmid">14566649</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.schimmenti.1995.204">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pierpont</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carpenter</surname>
                    <given-names>BL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kashtan</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>Autosomal dominant optic nerve colobomas, vesicoureteral reflux, and renal anomalies.</article-title>
                <source>Am J Med Genet</source>
                <year>1995</year>
                <volume>59</volume>
                <fpage>204</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">8588587</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.schimmenti.1999.369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shim</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wirtschafter</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panzarino</surname>
                    <given-names>VA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kashtan</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirkpatrick</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wargowski</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>France</surname>
                    <given-names>TD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michel</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dobyns</surname>
                    <given-names>WB</given-names>
                  </name>
                </person-group>
                <article-title>Homonucleotide expansion and contraction mutations of PAX2 and inclusion of Chiari 1 malformation as part of renal-coloboma syndrome.</article-title>
                <source>Hum Mutat</source>
                <year>1999</year>
                <volume>14</volume>
                <fpage>369</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">10533062</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.sikora.2001.291">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sikora</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zajaczkowska</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niedzielska</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <source>Pol Merkur Lekarski</source>
                <year>2001</year>
                <volume>10</volume>
                <fpage>291</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">11434182</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.tellier.2000.85">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tellier</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delezoide</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audollent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esnault</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Encha-Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lyonnet</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vekemans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Expression of the PAX2 gene in human embryos and exclusion in the CHARGE syndrome.</article-title>
                <source>Am J Med Genet</source>
                <year>2000</year>
                <volume>93</volume>
                <fpage>85</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10869107</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.thomas.2011.897">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thomas</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanna-Cherchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warady</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furth</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaskel</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gharavi</surname>
                    <given-names>AG</given-names>
                  </name>
                </person-group>
                <article-title>HNF1B and PAX2 mutations are a common cause of renal hypodsyplasia in the CKiD cohort.</article-title>
                <source>Pediatr Nephrol</source>
                <year>2011</year>
                <volume>26</volume>
                <fpage>897</fpage>
                <lpage>903</lpage>
                <pub-id pub-id-type="pmid">21380624</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.torban.2000.833">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Torban</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eccles</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favor</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodyer</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <article-title>PAX2 suppresses apoptosis in renal collecting duct cells.</article-title>
                <source>Am J Pathol</source>
                <year>2000</year>
                <volume>157</volume>
                <fpage>833</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">10980123</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.verloes.1989.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verloes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lambotte</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Further delineation of a syndrome of cerebellar vermis hypo/aplasia, oligophrenia, congenital ataxia, coloboma, and hepatic fibrosis.</article-title>
                <source>Am J Med Genet</source>
                <year>1989</year>
                <volume>32</volume>
                <fpage>227</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">2929661</pub-id>
              </element-citation>
            </ref>
            <ref id="papr.REF.weber.2006.2864">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moriniere</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knuppel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charbit</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghiggeri</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jankauskiene</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mir</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peco-Antic</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuhl</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zurowska</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mehls</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salomon</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Prevalence of mutations in renal developmental genes in children with renal hypodysplasia: results of the ESCAPE study.</article-title>
                <source>J Am Soc Nephrol</source>
                <year>2006</year>
                <volume>17</volume>
                <fpage>2864</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">16971658</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="papr.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="papr.Suggested_Reading.reflist0">
            <ref id="papr.REF.eccles.2004.1">
              <mixed-citation publication-type="book">Eccles MR. PAX2 and renal-coloboma syndrome. In: Epstein C, Erickson R, Wynshaw-Boris A, eds. <italic toggle="yes">Inborn Errors of Development</italic>. San Francisco, CA: Oxford University Press; 2004:796-801.</mixed-citation>
            </ref>
            <ref id="papr.REF.eccles.2003.1">
              <mixed-citation publication-type="book">Eccles MR, Bockett N, Stayner C. PAX2 and renal-coloboma syndrome. In: Vize PD, Woolf AS, Bard JBL, eds. <italic toggle="yes">The Kidney: From Normal Development to Congenital Abnormalities</italic>. London, UK: Academic Press; 2003:411-31.</mixed-citation>
            </ref>
            <ref id="papr.REF.horsford.2002.1">
              <mixed-citation publication-type="book">Horsford DJ, Hanson I, Freund F, McInnes RR, van Heyningen V. Transcription factors in eye disease and ocular development. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. Chap 240. New York, NY: McGraw-Hill; 2002.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="papr.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="papr.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>20 November 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>12 July 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 June 2007 (me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>8 December 2006 (las) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
